Subordination Agreement in the Pharmaceuticals Industry
24 Contracts & Agreements
- ACURA PHARMACEUTICALS, INC (1 contract)
- Akorn (2)
- Ampio Pharmaceuticals, Inc. (3)
- BODY & MIND INC. (1)
- Clever Leaves Holdings Inc. (1)
- COLLEGIUM PHARMACEUTICAL, INC (2)
- Evofem Biosciences, Inc. (1)
- Evolus, Inc. (3)
- Jaguar Health, Inc. (2)
- Neos Therapeutics, Inc. (1)
- OCULAR THERAPEUTIX, INC (1)
- ORAMED PHARMACEUTICALS INC. (1)
- Processa Pharmaceuticals, Inc. (1)
- Rib-X Pharmaceuticals, Inc. (1)
- TILT Holdings Inc. (3)
- Subordination Agreement, dated October 8, 2024, by and among Scilex Pharmaceuticals Inc., Acquiom Agency Services LLC and other signatories thereto (ORAMED PHARMACEUTICALS INC., Filed With SEC on October 8, 2024)
- Consent, Collateral Release and Subordination Agreement, dated May 2, 2024, by and between Standard Farms LLC, Baker Technologies, Inc., New Lender, Shenzhen Smoore Technology... (TILT Holdings Inc., Filed With SEC on August 9, 2024)
- Subordination and Intercreditor Agreement, dated January 28, 2024, by and between Entrepreneur Growth Capital LLC, Jordan Geotas, Shenzhen Smoore Technology Limited, and Jupiter... (TILT Holdings Inc., Filed With SEC on January 31, 2024)
- Subordination and Intercreditor Agreement dated May 15, 2023, by and among Entrepreneur Growth Capital LLC, TILT Holdings Inc., and Jupiter Research, LLC (TILT Holdings Inc., Filed With SEC on May 19, 2023)
- Subordination Agreement BAM I, A Series of Bengal Catalyst Fund SPV, LP, Mindset Value Fund LP and Mindset Value Wellness Fund LP, Body and Mind Inc., DEP Nevada, Inc., Nevada... (BODY & MIND INC., Filed With SEC on December 23, 2022)
- Subordination Agreement, dated as of September 15, 2022, by and among Global Health Technology Fund, LP, Adjuvant Global Health Technology Fund, DE, LP, and certain institutional... (Evofem Biosciences, Inc., Filed With SEC on September 16, 2022)
- Subordination Agreement, entered into as of July 19, 2021, by and between Catalina LP and Rock Cliff Capital LLC (Clever Leaves Holdings Inc., Filed With SEC on July 19, 2021)
- Subordination Agreement, by and among Neos, Aytu, Deerfield Private Design Fund III, L.P. and Deerfield Partners, L.P (Neos Therapeutics, Inc., Filed With SEC on February 8, 2021)
- Subordination Agreement. dated July 6, 2020, by and among Evolus, Inc., Oxford Finance, LLC and Daewoong Pharmaceutical Co. Ltd (Evolus, Inc., Filed With SEC on July 7, 2020)
- Subordination Agreement, dated as of February 21, 2019, by and among Ocular Therapeutix, Inc., MidCap Financial Trust, as administrative agent, and the Lenders listed therein (OCULAR THERAPEUTIX, INC, Filed With SEC on February 22, 2019)
- Subordination Agreement dated as of May 7, 2018 between John Schutte and Oxford Finance, LLC, approved by Registrant and Acura Pharmaceutical Technologies, Inc (ACURA PHARMACEUTICALS, INC, Filed With SEC on August 14, 2018)
- Subordination Agreement, dated as of December 14, 2017, by and among Dental Innovations BVBA, Longitude Venture Partners II, L.P., ALPHAEON Corporation and SCH-AEON, LLC (formerly... (Evolus, Inc., Filed With SEC on January 9, 2018)
- Subordination Agreement, dated as of December 14, 2017, by and among Dental Innovations BVBA, Longitude Venture Partners II, L.P., ALPHAEON Corporation, the Registrant and J.... (Evolus, Inc., Filed With SEC on January 9, 2018)
- SUBORDINATION AGREEMENT AND RIGHT TO PURCHASE DEBT (Jaguar Health, Inc., Filed With SEC on July 3, 2017)
- LIMITED SUBORDINATION AGREEMENT (Jaguar Health, Inc., Filed With SEC on April 18, 2017)
- SUBORDINATION AGREEMENT (COLLEGIUM PHARMACEUTICAL, INC, Filed With SEC on April 2, 2015)
- SUBORDINATION AGREEMENT (COLLEGIUM PHARMACEUTICAL, INC, Filed With SEC on April 2, 2015)
- SUBORDINATION AGREEMENT (Processa Pharmaceuticals, Inc., Filed With SEC on May 23, 2013)
- SUBORDINATION AGREEMENT (Rib-X Pharmaceuticals, Inc., Filed With SEC on March 2, 2012)
- DMI LIFE SCIENCES, INC. NOTE EXTENSION AND SUBORDINATION AGREEMENT (Ampio Pharmaceuticals, Inc., Filed With SEC on February 15, 2011)
- DMI LIFE SCIENCES, INC. NOTE EXTENSION AND SUBORDINATION AGREEMENT (Ampio Pharmaceuticals, Inc., Filed With SEC on February 15, 2011)
- AMPIO PHARMACEUTICALS, INC. NOTE EXTENSION AND SUBORDINATION AGREEMENT (Ampio Pharmaceuticals, Inc., Filed With SEC on February 15, 2011)
- SUBORDINATION AGREEMENT (Akorn, Filed With SEC on January 9, 2009)
- SUBORDINATION AND INTERCREDITOR AGREEMENT (Akorn, Filed With SEC on August 1, 2008)